Question 1

What specific benefits do you think AXA1125 could provide for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis clinical trial (NCT04880187). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis clinical trial (NCT04880187). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of AXA1125?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis clinical trial (NCT04880187). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis clinical trial (NCT04880187). Contact the study team or your healthcare provider for specific answers.

Question 5

What will the liver biopsy involve, and why is it necessary?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis clinical trial (NCT04880187). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis clinical trial (NCT04880187). Contact the study team or your healthcare provider for specific answers.

What this study is about